| Accession Number: | 0001209191-21-050976 |
| Date: | 2021-08-10 |
| Issuer: | NURIX THERAPEUTICS, INC. (NRIX) |
| Original Submission Date: |
BEAURANG PIERRE
C/O NURIX THERAPEUTICS, INC.
1700 OWENS STREET, SUITE 205
SAN FRANCISCO, CA 94158
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-08-10 | M | 7,500 | a | $1.11 | 11,830 | direct | ||
| COMMON STOCK | 2021-08-10 | S | 5,620 | d | $29.74 | 6,210 | direct | ||
| COMMON STOCK | 2021-08-10 | S | 1,880 | d | $30.21 | 4,330 | direct | ||
| COMMON STOCK | 2021-08-10 | 0 | $0.00 | 116,666 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 1.11 | 2021-08-10 | deemed execution date | M | 7,500 (d) | 2027-02-01 | common stock 7,500 | $1.11 | 6,562 | direct |
| ID | footnote |
|---|---|
| f1 | this transaction was effected pursuant to a rule 10b5-1 trading plan previously adopted by the reporting person. |
| f2 | represents the weighted average sale price. the lowest price at which shares were sold was $29.07 and the highest price at which shares were sold was $30.06. the reporting person undertakes to provide upon request to the staff of the securities and exchange commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this form 4. |
| f3 | represents the weighted average sale price. the lowest price at which shares were sold was $30.07 and the highest price at which shares were sold was $30.34. |
| f4 | the reporting person is a trustee of the beaurang-sligh family trust. the reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of section 16 or for any other purposes. |
| f5 | the option is fully vested. |
